Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|August 10, 2023
Impact of meteorological and demographic factors on the influenza epidemic in Japan: a large observational database studyGenta Ito, Takahiro Takazono, Naoki Hosogaya, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2023
Pathogenic LRRK2 compromises the subcellular distribution of lysosomes in a Rab12-RILPL1-dependent mannerKyohei Ito, Miho Araki, Yuta Katai, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJohn M Hatcher, Jinwei Zhang, Hwan Geun Choi, et al.
Journal of Medicinal Chemistry|April 22, 2015
Structural Characterization of LRRK2 InhibitorsBernd K Gilsbach, Ana C Messias, Genta Ito, et al.
Veterinary Research Communications|September 6, 2023
Detection of feline morbillivirus in cats with symptoms of acute febrile infectionGenta Ito, Shoichi Tabata, Aya Matsuu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 23, 2024
Wastewater-based reproduction numbers and projections of COVID-19 cases in three areas in Japan, November 2021 to December 2022Shogo Miyazawa, Ting Sam Wong, Genta Ito, et al.
Influenza and Other Respiratory Viruses|August 27, 2024
Comparison of the Effectiveness of Baloxavir and Oseltamivir in Outpatients With Influenza BTakahiro Takazono, Genta Ito, Naoki Hosogaya, et al.
Molecular Neurodegeneration|December 2, 2006
LRRK2 in Parkinson's disease and dementia with Lewy bodiesXiongwei Zhu, Asim Babar, Sandra L Siedlak, et al.
Neuro-Degenerative Diseases|March 7, 2008
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathiesGeorge Perry, Xiongwei Zhu, Asim K Babar, et al.
Plos One|July 14, 2021
Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapyGenta Ito, Kazuyoshi Kawakami, Takeshi Aoyama, et al.
Pageof 6